Loading...
OTCM
KBLB
Market cap92mUSD
Dec 05, Last price  
0.09USD
1D
0.23%
1Q
3.14%
Jan 2017
59.63%
IPO
70.80%
Name

Kraig Biocraft Laboratories Inc

Chart & Performance

D1W1MN
OTCM:KBLB chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
4.44%
Rev. gr., 5y
137.13%
Revenues
0k
000000000031,85897,318401,620000000
Net income
-3m
L+12.19%
-530,321-472,986-360,104-2,793,143-1,782,888-1,295,310-1,202,921-7,467,685-1,872,987-2,133,793-3,073,843-2,333,100-1,168,977-3,204,202-5,357,901-8,706,222-5,562,685-3,029,780-3,399,000
CFO
-2m
L+47.78%
-10,010-411,067-96,281-132,967-195,450-556,096-562,922-800,154-904,559-967,563-1,011,841-729,542-235,005-1,087,881-1,254,712-1,800,809-1,887,187-1,244,483-1,839,086

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
IPO date
Feb 29, 2008
Employees
36
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT